Related Experiment Videos

The FDA's Regulatory Framework for Chimeric Antigen Receptor-T Cell Therapies

¹Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.

Clinical and Translational Science

|July 23, 2019

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Limb-Girdle Muscular Dystrophy Scientific Workshop: A Multistakeholder Discussion Focused on Charting the Path Forward for Drug Development.

Neurology. Clinical practice·2025

Performance of a whole blood immunoassay for tenofovir detection and correlation with self-reported pre-exposure prophylaxis use in HIV-negative men who have sex with men interested in blood donation.

Transfusion·2025

Comparative evaluation of swabbing sites for Omicron variant detection in PCR testing.

Diagnostic microbiology and infectious disease·2024

The value of observational registry studies for the next infectious disease emergency.

mBio·2023

Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2023

Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development.

The journals of gerontology. Series A, Biological sciences and medical sciences·2023

See all related articles